Market Place
Sourcing Support
BioAffinity`s CyPath Lung Helps Skip Biopsies
17 Mar 2026 //
BUSSINESSWIRE
BioAffinity Technologies Reports Record 2025 Revenue & Sales
13 Mar 2026 //
PHARMIWEB
Bioaffinity Technologies Releases Q3 2025 Financial Report
14 Nov 2025 //
BUSINESSWIRE
Wallachbeth Capital Closes $1.8M Bioaffinity Tech Stock Financing
09 Oct 2025 //
PR NEWSWIRE
Bioaffinity Technologies Closes $1.8M Direct Stock Financing
09 Oct 2025 //
BUSINESSWIRE
CyPath Lung Tool Improves Lung Cancer Detection in Veterans
03 Sep 2025 //
BUSINESSWIRE
bioAffinity Technologies Reports $9.4M Revenue in 2024
31 Mar 2025 //
BUSINESSWIRE
bioAffinity Closes $1.4M Warrant Inducement Transaction
26 Feb 2025 //
BUSINESSWIRE
bioAffinity Raises $1.4M Through Warrant Inducement
25 Feb 2025 //
BUSINESSWIRE
BioAffinity Technologies CFO Departs, J. Michael Edwards Returns As Interim
23 Aug 2024 //
BUSINESSWIRE
bioAffinity Reports $2.4M Q2 Revenue Boosted By CyPath® Lung Sales
14 Aug 2024 //
BUSINESSWIRE
bioAffinity Tech Closes $1.75M Offering And Warrant Inducement
05 Aug 2024 //
BUSINESSWIRE
bioAffinity Technologies Prices $1.75M Offering
02 Aug 2024 //
BUSINESSWIRE
BioAffinity Reports Growth In CyPath Lung Test Orders
12 Jun 2024 //
BUSINESSWIRE
bioAffinity Reports Record Q1 Driven By CyPath Lung, Lab Growth
15 May 2024 //
BUSINESSWIRE
bioAffinity Technologies News Update
02 May 2024 //
BUSINESSWIRE
bioAffinity Advances Product Development Initiatives
24 Apr 2024 //
BUSINESSWIRE
bioAffinity Reports Fourth Quarter and Full Year 2023 Financial Results
01 Apr 2024 //
BUSINESSWIRE
bioAffinity Announces Closing of $2.5 Million Registered Direct Offering
08 Mar 2024 //
BUSINESSWIRE
bioAffinity Announces Pricing of $2.5 Million Registered Direct Offering
06 Mar 2024 //
BUSINESSWIRE
bioAffinity Announces Award of Therapeutic Patent for Treatment of Cancer
23 Jan 2024 //
BUSINESSWIRE
bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors
05 Dec 2023 //
BUSINESSWIRE
bioAffinity VP David Elzi Named to American Society for Cell Biology Post
28 Nov 2023 //
BUSINESSWIRE
bioAffinity Teams with Cancer Society to Raise Funds for Lung Cancer Screening
15 Nov 2023 //
BUSINESSWIRE
bioAffinity Technologies Reports Third Quarter 2023 Financial Results
14 Nov 2023 //
BUSINESSWIRE
bioAffinity to Present at 8th Annual Dawson James Small Cap Growth Conference
10 Oct 2023 //
BUSINESSWIRE
bioAffinity Acquires Laboratory Assets of Precision Pathology Services
19 Sep 2023 //
BUSINESSWIRE
bioAffinity to Participate in the H.C. Wainwright Global Investment Conference
07 Sep 2023 //
BUSINESSWIRE
bioAffinity Technologies Reports Second Quarter 2023 Financial Results
14 Aug 2023 //
BUSINESSWIRE
bioAffinity Presents Research Findings at UMass RNA Therapeutics Symposium
15 Jun 2023 //
BUSINESSWIRE
bioAffinity Technologies Reports First Quarter 2023 Financial Results
15 May 2023 //
BUSINESSWIRE
bioAffinity Technologies Names Michael Dougherty CFO
01 May 2023 //
CONTRACT PHARMA
bioAffinity Technologies to Ring Nasdaq Closing Bell Today
05 Apr 2023 //
BUSINESSWIRE
bioAffinity Announces Publication of Paper on Proprietary Beads Used in CyPath
28 Mar 2023 //
BUSINESSWIRE
bioAffinity to Report Fourth Quarter 2022 Financial Results on March 31, 2023
24 Mar 2023 //
BUSINESSWIRE
bioAffinity Announces Publication of Results of Trial in Journal Respiratory Research
24 Jan 2023 //
BUSINESSWIRE
bioAffinity Announces Notice to Award U.S. Patent Protecting Novel Compounds
04 Jan 2023 //
BUSINESSWIRE
bioAffinity Technologies to Report Third Quarter 2022 Financial Results
08 Nov 2022 //
BUSINESSWIRE
